Cargando…
Inferring SARS-CoV-2 functional genomics from viral transcriptome with identification of potential antiviral drugs and therapeutic targets
Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and has posed a serious threat to global health. Here, we systematically characterized the transcription levels of the SARS-CoV-2 genes and identified the...
Autores principales: | Pan, Xu, Li, Xin, Ning, Shangwei, Zhi, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424170/ https://www.ncbi.nlm.nih.gov/pubmed/34496960 http://dx.doi.org/10.1186/s13578-021-00684-4 |
Ejemplares similares
-
Sars-Cov-2 and risk of antiviral drug resistance
por: Vitiello, Antonio
Publicado: (2021) -
Antiviral Drugs for Viral Pneumonia
por: Bansal, Tapesh
Publicado: (2023) -
Synergism of interferon-beta with antiviral drugs against SARS-CoV-2 variants
por: Bojkova, Denisa, et al.
Publicado: (2022) -
Aminoglycosides and their potential as SARS-CoV-2 antivirals
por: Cimolai, Nevio
Publicado: (2021) -
RNA editing detection in SARS-CoV-2 transcriptome should be different from traditional SNV identification
por: Cai, Houhao, et al.
Publicado: (2022)